Loading provider…
Loading provider…
Diagnostic Radiology Physician in Long Beach, CA
NPI: 1003055401Primary Employer
Imaging Healthcare Specialists
imaginghealthcare.com
HQ Phone
Get MD Jackson's Phone Numberphone_androidMobile
Get MD Jackson's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2010 - 2026
NM State Medical License
2019 - 2026
WA State Medical License
2019 - 2022
FL State Medical License
2007 - 2013

American Board of Radiology
Diagnostic Radiology

American Board of Radiology
Neuroradiology
UCLA David Geffen School of Medicine/UCLA Medical Center
Fellowship • Neuroradiology
2011 - 2012
Mayo Clinic College of Medicine and Science (Jacksonville)
Residency • Radiology-Diagnostic
2007 - 2011
OhioHealth/Riverside Methodist Hospital
Internship • Transitional Year
2006 - 2007
Princeton University
BA • Molecular Biology
1997 - 2002
Ohio State College of Medicine
medicine.osu.edu
Medical School
Until 2006
Mayo Clinic Alix School of Medicine - Rochester
college.mayo.edu
Residency • Radiology-Diagnostic
2007 - 2011
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 71045X-ray of chest, 1 view | 607 | 658 |
| 2 | 70450CT scan head or brain | 526 | 563 |
| 3 | 72125Ct scan of upper spine without contrast | 183 | 187 |
| 4 | 71046X-ray of chest, 2 views | 159 | 163 |
| 5 | 70551MRI scan brain | 110 | 111 |
Formation of a Stable Heterodimer between Smad2 and Smad4
Authors: Jia-Wei Wu, Robert Fairman, Jack Penry, Yigong Shi
Lead Sponsor: Intercept Pharmaceuticals
Intervention / Treatment: DRUG: Matching Placebo, DRUG: OCA
Lead Sponsor: Riphah International University
Intervention / Treatment: OTHER: Pilates Exercise - Online, OTHER: Pilates Exercise - Supervised
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Enzalutamide, DRUG: Abiraterone, DRUG: JSB462